Biotechnology Roche’s Lymphoma Drug With Chemo Extends Survival In Pretreated Patients – Roche Holding (OTC:RHHBY) Read more
Biotechnology AstraZeneca/Daiichi’s Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor – AstraZeneca (NASDAQ:AZN) Read more
Biotechnology FDA Approves Bristol-Myers/2seventy Bio’s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer – 2seventy bio (NASDAQ:TSVT), Bristol-Myers Squibb (NYSE:BMY) Read more
Biotechnology FDA Approves Johnson & Johnson’s Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients – Johnson & Johnson (NYSE:JNJ) Read more